期刊文献+

树突状细胞疫苗在宫颈癌治疗中的研究进展 被引量:1

Progress in the study on dendritic cell vaccine for immunotherapy of cervical cancer
暂未订购
导出
摘要 树突状细胞是至今发现的功能最强的专职抗原提呈细胞 ,人们能通过各种刺激提高其抗原提呈能力和诱导T细胞应答能力 ,本文简单介绍了树突状细胞疫苗在宫颈癌的免疫治疗方面的新进展。 Dendritic cell is the most potent antigen presenting cell in immune system. People do many things to stimulate it, and want to make it either presents antigen more effectively or induces more powerful CTL response. In this review, we introduced some new methods to enhance DC's presenting ability in immunotherapy of cervical cancer.
作者 吴砂 张昌菊
出处 《国外医学(妇幼保健分册)》 2003年第3期170-173,共4页 Foreign Medical Sciences (Section of Maternal and Child Health)
关键词 树突状细胞 宫颈癌 免疫治疗 树突状细胞疫苗 免疫应答 dendritic cell, cervical cancer, immunotherapy
  • 相关文献

参考文献19

  • 1Muderspach L, Wilczymski S, Roman L, et al. A phase I trial of a human papillomavirus (HPV) peptide vaccine for woman with high-grade cervical and vulvar intraepithelial neoplasia who are HPV positive[J]. Clin Cancer Res,2000,6(9) :3406 - 3416.
  • 2Davidson El, Brown MD, Burt DS, et al. Human T cell response to HPV16E2 -enerated with monocyte-derived dendritic cell[J]. Int J Cancer,2001,94(6) :807 - 812.
  • 3Chiriva IM, Liu Y, Salati E, et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16E7 antigen gene transduction in dendritic cells [J]. Ear J Immunol,2002,32(1) :30 - 38.
  • 4Wang TL, Ling M, Shill IM, et al. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity [J]. CJene Ther, 2000,7 (9) : 726 - 733.
  • 5Mitchell DA, Nair SK, Gilboa E, et al. Dendritic cell/ macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells [ J ]. Eur J Immunol, 1998,28 (6) : 1923 - 1933.
  • 6Thornberg C, Boczkowski D, Gilboa E, et al. Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implication for cervical cancer immunotherapy [J]. J Immuno Ther,2000,23(4) :412- 418.
  • 7Rudolf MP, Fausch SC, Silva DM, et al. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitopc-specific human T responses in vitro[J]. J Immunol,2001,166(10):5917 - 5974.
  • 8E 17 ] Cao X, Zhang W, Wang J, et al. Therapy of established tumor with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulatin factor genet- ically modified dendritic cells[J]. J Immunol, 1999,97 (4) :616- 625.
  • 9Moghaddami M, Swart B, Reynolds P, et al. Fit3 ligand expands dendritic cell numbers in normal and malignant murineprostate[J]. Immunol Cell Biol, 2002,80(4) :370-381.
  • 10Hubert P, Greimers R, Franzen DE, et al. In vitro propagated dendritic cells from patients with human-pilloma virus-associated preneoplastic lesions of the uterine cervix:use of Fit3 ligand [ J ]. Cancer Immunol Immunother, 1998,47(2) :81 - 89.

同被引文献19

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部